GN Store Nord (GN) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
23 Nov, 2025Executive summary
Achieved strong execution in Q2 2025 despite global trade uncertainties and weak macro conditions, with market share gains in Hearing and Gaming and solid margin progression.
EBITA rose 46% year-over-year to DKK 546 million (13.1% margin), driven by gross margin improvements and cost discipline, with no extraordinary costs.
Free cash flow (excluding M&A) reached DKK 353 million, and leverage was reduced to 4.0x from 4.9x.
Gained market share in Hearing with 8% organic growth, driven by the launch of ReSound Vivia and Enzo IA.
Gaming achieved 0% organic growth in a declining market, taking share despite tariff and sentiment headwinds.
Financial highlights
Group revenue was DKK 4,160 million, with organic revenue growth at 0% (excluding wind-down effect); reported organic growth was -5%.
Gross margin improved by 3.7 percentage points to 55.6%, driven by pricing discipline and favorable business mix.
EBITA margin increased to 13.1%, supported by cost management and no extraordinary costs.
Free cash flow (excl. M&A) was DKK 353 million.
Profit before tax reached DKK 232 million, with a net profit of DKK 180 million and EPS of DKK 1.13.
Outlook and guidance
2025 organic revenue growth guidance (excl. wind-down) narrowed to -2% to +2%; EBITA margin guidance remains at 11–13%.
Hearing expected at the lower end of its range due to softer North America and market growth; Gaming trending mid-range.
Tariffs expected to impact EBITA margin by around -1% for the year.
Free cash flow (excl. M&A) guidance at DKK 800 million.
Wind-down effect expected to reduce reported organic revenue growth by about 3 percentage points.
Latest events from GN Store Nord
- Hearing business sold to Amplifon for DKK 17B, enabling tech focus and global audiology leadership.GN
M&A announcement16 Mar 2026 - Guiding for 3%-7% organic growth and margin expansion in 2026, led by innovation and cost control.GN
Q4 20255 Feb 2026 - Pursuing margin expansion and growth through innovation in hearing, enterprise, and gaming.GN
SEB Nordic Seminar presentation5 Feb 2026 - 5% organic growth and margin gains, with strong Hearing and Gaming, guidance confirmed.GN
Q2 202423 Jan 2026 - Record cash flow and margin gains as Hearing outperformed, offsetting mixed divisional growth.GN
Q3 202416 Jan 2026 - Strong EBITDA growth, new board members, and strategic focus on innovation and resilience.GN
AGM 202520 Dec 2025 - Strong 2024 growth and margin gains set the stage for further expansion in 2025.GN
Q4 202417 Dec 2025 - Organic revenue fell 3%, but margin gains and new launches support cautious optimism.GN
Q1 202529 Nov 2025 - Q3 2025 saw 1% organic growth, 11% EBITA margin, and strong cash flow, led by Hearing.GN
Q3 202513 Nov 2025